Dr. Rajneesh Nath, MD
Claim this profileBanner MD Anderson Cancer Center
Studies Mixed-Cell Lymphoma
Studies Non-Hodgkin's Lymphoma
13 reported clinical trials
24 drugs studied
Area of expertise
1Mixed-Cell Lymphoma
CD19 positive
Philadelphia chromosome positive
2Non-Hodgkin's Lymphoma
CD19 positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Rajneesh Nath, MD is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
DFP-10917
for Acute Myeloid Leukemia
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior induction regimens: Experimental arm: DFP-10917 14-day continuous intravenous (IV) infusion at a dose of 6 mg/m²/day followed by a 14-day resting period per 28-day cycles. Control arm: Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens), depending on the patient's prior induction treatment.
Recruiting2 awards Phase 34 criteria
More about Rajneesh Nath, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Rajneesh Nath, MD has experience with
- Fludarabine
- Cyclophosphamide
- Lenalidomide
- Idecabtagene Vicleucel
- Iadademstat
- Gilteritinib
Breakdown of trials Rajneesh Nath, MD has run
Mixed-Cell Lymphoma
- AB-205 for Lymphoma
- A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
- PBCAR0191 for Blood Cancer
Non-Hodgkin's Lymphoma
Acute Myelogenous Leukemia
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajneesh Nath, MD specialize in?
Rajneesh Nath, MD focuses on Mixed-Cell Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Mixed-Cell Lymphoma has involved CD19 positive patients, or patients who are Philadelphia chromosome positive.
Is Rajneesh Nath, MD currently recruiting for clinical trials?
Yes, Rajneesh Nath, MD is currently recruiting for 8 clinical trials in Gilbert Arizona. If you're interested in participating, you should apply.
Are there any treatments that Rajneesh Nath, MD has studied deeply?
Yes, Rajneesh Nath, MD has studied treatments such as Fludarabine, Cyclophosphamide, Lenalidomide.
What is the best way to schedule an appointment with Rajneesh Nath, MD?
Apply for one of the trials that Rajneesh Nath, MD is conducting.
What is the office address of Rajneesh Nath, MD?
The office of Rajneesh Nath, MD is located at: Banner MD Anderson Cancer Center, Gilbert, Arizona 85234 United States. This is the address for their practice at the Banner MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.